Clinical trials
Phase 2 Fibrosis trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 4 |
| 2016 | 3 |
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 7 |
| Active, not recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 4 |
| Novartis Pharmaceuticals | 3 |
| AstraZeneca | 1 |
| Axcella Health, Inc | 1 |
| Celgene | 1 |
| Conatus Pharmaceuticals Inc. | 1 |
| Genfit | 1 |
| Hoffmann-La Roche | 1 |
| Intercept Pharmaceuticals | 1 |
| Inventiva Pharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 21 |
| Non-alcoholic Fatty Liver Disease | 5 |
| Idiopathic Pulmonary Fibrosis | 4 |
| Liver Cirrhosis | 3 |
| Lung Diseases, Interstitial | 3 |
| Fatty Liver | 2 |
| Hepatitis, Alcoholic | 2 |
| Liver Diseases | 2 |
| Lung Diseases | 2 |
| Pulmonary Fibrosis | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.